Please use this identifier to cite or link to this item: http://hdl.handle.net/1959.13/916793
- Societal preference values for advanced melanoma health states in the United Kingdom and Australia
Beusterien, K. M.;
Szabo, S. M.;
Middleton, M. R.;
Levy, A. R.
- The University of Newcastle. Faculty of Health, School of Medicine and Public Health
- No studies measure preference-based utilities in advanced melanoma that capture both intended clinical response and unintended toxicities associated with treatment. Using standard gamble, utilities were elicited from 140 respondents in the United Kingdom and Australia for 13 health states. Preferences decreased with reduced treatment responsiveness and with increasing toxicity. These general population utilities can be incorporated into treatment-specific cost-effectiveness evaluations.
- British Journal of Cancer Vol. 101, Issue 3, p. 387-389
- Publisher Link
- Nature Publishing Group
- Resource Type
- journal article